Physician profile
Roberto Salvatori
NPI 1063444529
$53,268.06
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $4,553 · 2021: $8,190 · 2022: $4,942 · 2023: $17K · 2024: $5,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Honoraria: $4,895 · Travel and Lodging: $2,878 · Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,684.09 |
| Honoraria | $4,895.00 |
| Travel and Lodging | $2,878.40 |
| Food and Beverage | $686.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $24,017.36 | 2019-2023 | Norditropin |
| Amryt Pharma Holdings LTD | $7,926.02 | 2023 | Mycapssa |
| Chiesi USA, INC. | $5,993.18 | 2024 | Mycapssa |
| Ipsen Biopharmaceuticals, INC | $3,440.00 | 2021 | |
| Ascendis Pharma Endocrinology INC | $3,376.00 | 2023 | |
| Recordati_rare_diseases_inc. | $3,093.93 | 2021-2022 | |
| Hra Pharma Rare Diseases | $2,000.00 | 2021 | |
| Strongbridge US INC. | $1,800.00 | 2020 | |
| H. Lundbeck A S | $1,500.00 | 2023 | |
| Corcept Therapeutics | $121.57 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Salvatori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.